| Trial ID: | L4025 |
| Source ID: | NCT01456650
|
| Associated Drug: |
Glyburide
|
| Title: |
R230C and C230C Variants of ABCA1 and Glyburide Response
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Glyburide
|
| Outcome Measures: |
Primary: Change in plasma fasting glucose, The effects of the alleles under study on the glucose lowering effect of glyburide will be assessed in 20 week study. Diet and exercise will be controlled per protocol, 20 weeks | Secondary: HbA1c levels, 20 weeks
|
| Sponsor/Collaborators: |
Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
85
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2011-03
|
| Completion Date: |
2012-12
|
| Results First Posted: |
|
| Last Update Posted: |
2014-01-15
|
| Locations: |
Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, DF, 14000, Mexico
|
| URL: |
https://clinicaltrials.gov/show/NCT01456650
|
